Showing 801 - 820 results of 1,102 for search '"type 2 diabetes mellitus"', query time: 0.07s Refine Results
  1. 801

    Effect of Liraglutide on Serum TSH Levels in Patients with NAFLD and its Underlying Mechanisms by JiaoJiao Ye, Jing Xu, WenJie Wen, Bin Huang

    Published 2022-01-01
    “…This study aimed to evaluate the effect of liraglutide on serum thyroid-stimulating hormone (TSH) levels in patients with type 2 diabetes mellitus (T2DM) and explore the underlying mechanisms via bioinformatics analysis. …”
    Get full text
    Article
  2. 802

    Pengaruh Kombinasi Metformin dan Ekstrak Kunyit terhadap Kadar High Density Lipoprotein, Interleukin-6 dan Tumor Necrosis Factor-a by Fathia Kesuma Dinanti, Sri Priyantini Mulyani, Chodidjah - -

    Published 2023-04-01
    “…A  decrease in high-density lipoprotein (HDL) happens in type 2 diabetes mellitus. The cytokines TNFa and IL-6 are proinflammatory cytokines that are elevated in the blood in many patients with DM. …”
    Get full text
    Article
  3. 803

    Squamous Cell Carcinoma of Nasofacial Groove by Tamajit Sau, Saumitra Kumar, Ankita Atin Mukherjee, Debalina Mazumdar

    Published 2024-05-01
    “…Case Report: A 65-year-old housewife with hypertension and type 2 Diabetes Mellitus presented with painless swelling over right nasofacial groove for last 5 months which was insidious in onset, gradually progressive to reach the present size. …”
    Get full text
    Article
  4. 804

    The Effect of Shear Force on Skin Viability in Patients with Type 2 Diabetes by Luuk A. de Wert, Margot Geerts, Sander van der Brug, Laura Adriaansen, Martijn Poeze, Nicolaas Schaper, Nicole D. Bouvy

    Published 2019-01-01
    “…Shear is a major risk factor in the development of diabetic foot ulcers, but its effect on the skin of patients with type 2 diabetes mellitus (DM) remains to be elucidated. The aim was to determine skin responses to shear in DM patients with and without diabetic polyneuropathy (DNP). …”
    Get full text
    Article
  5. 805

    Characteristics and Clinical Course of Patients with Acute Myocardial Infarction and ST-segment Elevation with and without Interatrial Block by Francisco de Jesús Valladares Carvajal, Verónica Mercedes Carretero Acosta, Raimundo Carmona Puerta, Aymara Marcia Hernández Cardoso, Ernesto Julio Bernal Valladares

    Published 2023-08-01
    “…Demographic variables were analyzed: age, sex, skin color and between clinics: toxic habits; (smoker, ex-smoker); medical history (myocardial infarction, angina, peripheral arterial disease, arterial hypertension, type 2 diabetes mellitus, chronic kidney disease; infarct location (anterior, inferior, left bundle branch block); complications: heart failure, atrial fibrillation, ventricular tachycardia/ventricular fibrillation, atrioventricular conduction disorders, mechanical complication, post infarction angina, arterial embolism) and discharge status (alive or deceased). …”
    Get full text
    Article
  6. 806

    Ficus carica and Sizigium cumini Regulate Glucose and Lipid Parameters in High-Fat Diet and Streptozocin-Induced Rats by El-Shaimaa A. Arafa, Waseem Hassan, Ghulam Murtaza, Manal Ali Buabeid

    Published 2020-01-01
    “…Results showed that both FC.Cr. and SC.Cr. have the potential to control obesity-linked type 2 diabetes mellitus (T2DM) by lowering the body weights, serum glucose, cholesterol, TG, LDL, and VLDL, while increasing the protective effects of HDL dose-dependently. …”
    Get full text
    Article
  7. 807

    Pancreatic Beta Cell Death: Novel Potential Mechanisms in Diabetes Therapy by Joselyn Rojas, Valmore Bermudez, Jim Palmar, María Sofía Martínez, Luis Carlos Olivar, Manuel Nava, Daniel Tomey, Milagros Rojas, Juan Salazar, Carlos Garicano, Manuel Velasco

    Published 2018-01-01
    “…Describing the diverse molecular mechanisms (particularly immunological) involved in the death of the pancreatic beta cell in type 1 and type 2 diabetes mellitus. Recent Findings. Beta cell death is the final event in a series of mechanisms that, up to date, have not been entirely clarified; it represents the pathophysiological mechanism in the natural history of diabetes mellitus. …”
    Get full text
    Article
  8. 808

    Liraglutide Attenuates Hepatic Oxidative Stress, Inflammation, and Apoptosis in Streptozotocin-Induced Diabetic Mice by Modulating the Wnt/β-Catenin Signaling Pathway by Jie Yu, Yuan Zhao, Lingling Xu, Wei Li, Huabing Zhang, Fan Ping, Yuxiu Li

    Published 2023-01-01
    “…Liraglutide has been extensively applied in the treatment of type 2 diabetes mellitus and also has hepatoprotective effects. …”
    Get full text
    Article
  9. 809

    Choroidal Thickness and Urinary Albumin Excretion in Type 2 Diabetic Patients without Retinopathy by Cláudia Oliveira-Ferreira, Mariana Leuzinger-Dias, João Tavares-Ferreira, F. Falcão-Reis, Amândio Rocha-Sousa

    Published 2020-01-01
    “…Inclusion criteria were diagnosis of type 2 diabetes mellitus, absence of diabetic retinopathy, and a 24 hours urinary albumin measurement in the last 3 months at the primary health-care center. …”
    Get full text
    Article
  10. 810

    Role of platelet indices and vitamin D in forecasting deterioration of glycemic control and vascular complications in type 2 diabetes by Maryam Ahmed Obaid Al Ali, Khalid Abdelsamea Mohamedahmed, Asaad Ma Babker

    Published 2025-01-01
    “… Type 2 diabetes mellitus (T2DM) is a prevalent chronic condition associated with various complications, including vascular ones. …”
    Get full text
    Article
  11. 811

    Electrochemical Skin Conductance May Be Used to Screen for Diabetic Cardiac Autonomic Neuropathy in a Chinese Population with Diabetes by Tianyi He, Chuan Wang, Anju Zuo, Pan Liu, Ruxing Zhao, Wenjuan Li, Li Chen, Xinguo Hou

    Published 2017-01-01
    “…We recruited 75 patients with type 2 diabetes mellitus (T2DM) and 45 controls without diabetes. …”
    Get full text
    Article
  12. 812

    Additive Effect of Sarcopenia and Anemia on the 10-Year Risk of Cardiovascular Disease in Patients with Type 2 Diabetes by Feihui Zeng, Lingning Huang, Yongze Zhang, Xinyu Hong, Suiyan Weng, Ximei Shen, Fengying Zhao, Sunjie Yan

    Published 2022-01-01
    “…A cross-sectional study was conducted involving 4673 hospitalized patients (2271 men and 2402 women) with type 2 diabetes mellitus, with an average age of 60.66±11.93 years, of whom 542 were followed up for a median follow-up period of 24 months. …”
    Get full text
    Article
  13. 813

    Monocyte to high-density lipoprotein cholesterol ratio as a marker of the presence and progression of diabetic kidney disease by Wentao Yang, Yuanlong Zhong, Pengying Zhou, Donghui Lu

    Published 2025-12-01
    “…Our research aimed to investigate the relationship between MHR and DKD.Methods This was a cross-sectional retrospective study of 159 participants with type 2 diabetes mellitus. MHR, urinary albumin-to-creatinine ratio (UACR) and other indexes were measured. …”
    Get full text
    Article
  14. 814

    Effectiveness of Vildagliptin in Clinical Practice: Pooled Analysis of Three Korean Observational Studies (the VICTORY Study) by Sunghwan Suh, Sun Ok Song, Jae Hyeon Kim, Hyungjin Cho, Woo Je Lee, Byung-Wan Lee

    Published 2017-01-01
    “…The present observational study aimed to evaluate the clinical effectiveness of vildagliptin with metformin in Korean patients with type 2 diabetes mellitus (T2DM). Data were pooled from the vildagliptin postmarketing survey (PMS), the vildagliptin/metformin fixed drug combination (DC) PMS, and a retrospective observational study of vildagliptin/metformin (fixed DC or free DC). …”
    Get full text
    Article
  15. 815

    Diabetes Mellitus and Increased Tuberculosis Susceptibility: The Role of Short-Chain Fatty Acids by Ekta Lachmandas, Corina N. A. M. van den Heuvel, Michelle S. M. A. Damen, Maartje C. P. Cleophas, Mihai G. Netea, Reinout van Crevel

    Published 2016-01-01
    “…Type 2 diabetes mellitus confers a threefold increased risk for tuberculosis, but the underlying immunological mechanisms are still largely unknown. …”
    Get full text
    Article
  16. 816

    The Effect of Whey Protein Consumption on Postprandial Glucose, Insulin and Incretin Responses in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Acute-Term... by Zahra Salimi, Maryam Asadi, Anahita Mansoori

    Published 2025-02-01
    “…This was a systematic review and meta-analysis that was conducted to evaluate the overall effect of whey protein consumption on postprandial glucose, insulin, and incretin hormone responses in patients with type 2 diabetes mellitus (T2DM). Methods: Web of Science, Cochrane Library, EMBASE, PubMed, and Scopus databases were searched to find acute-term controlled clinical trials investigating the effect of all types of whey proteins on products postprandial glucose (PPG) response as the main outcome and also insulin and incretin responses as secondary outcomes in patients with T2DM. …”
    Get full text
    Article
  17. 817

    Impact of hypertension on changes in peripapillary retinal nerve fiber layer thickness in type 2 diabetes patients by Jae-Yun Sung, Tae-Seen Kang, Ka-Hyun Lee, Min-Woo Lee

    Published 2025-01-01
    “…Abstract To determine longitudinal changes in the peripapillary retinal nerve fiber layer (pRNFL) thickness in type 2 diabetes mellitus (T2DM) patients with hypertension (HTN). …”
    Get full text
    Article
  18. 818

    Predictors of Insulin Resistance in Children versus Adolescents with Obesity by Yvette E. Lentferink, Marieke A. J. Elst, Catherijne A. J. Knibbe, Marja M. J. van der Vorst

    Published 2017-01-01
    “…Obesity is a risk factor to develop metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM). Insulin resistance (IR) plays a major part in both. …”
    Get full text
    Article
  19. 819

    Comparative Analysis of Biomarkers in Type 2 Diabetes Patients With and Without Comorbidities: Insights Into the Role of Hypertension and Cardiovascular Disease by Symeon Savvopoulos, Haralampos Hatzikirou, Herbert F Jelinek

    Published 2024-02-01
    “…Background: Type 2 diabetes mellitus (T2DM) are 90% of diabetes cases, and its prevalence and incidence, including comorbidities, are rising worldwide. …”
    Get full text
    Article
  20. 820

    Specialized Medical Weight Management Intervention for High-Risk Obesity by Gitanjali Srivastava, Chelsea Paris, Jessica Johnson, Emma Barnes, Brittany L. Cunningham, C. J. Stimson, Kevin D. Niswender, Sabrina J. Poon

    Published 2021-07-01
    “…The prevalence of any obesity-related medical condition was 54.1%; at least a quarter of the patients had either prediabetes or Type 2 diabetes mellitus, approximately a third had hypertension, and over 8% had hyperlipidemia. …”
    Get full text
    Article